v3.26.1
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash $ 8,890 $ 9,345
Trade accounts receivable, net of allowance for expected credit losses of $461 and $457, respectively 34,428 33,948
Inventories, net 57,286 54,008
Prepaid expenses and other current assets 9,499 8,500
Total current assets 110,103 105,801
Property, plant and equipment, net 40,117 40,397
Goodwill 45,329 45,376
Other intangible assets, net 10,651 10,933
Deferred income taxes, net 10,765 10,494
Other noncurrent assets 3,667 3,911
Total assets 220,632 216,912
Current liabilities:    
Accounts payable 24,058 17,423
Current portion of long-term debt 3,438 4,125
Accrued compensation and related benefits 2,854 2,754
Accrued expenses and other current liabilities 12,703 13,031
Total current liabilities 43,053 37,333
Long-term debt, net 44,190 45,526
Deferred income taxes 967 1,000
Other noncurrent liabilities 2,677 2,919
Total liabilities 90,887 86,778
Commitments and Contingencies  
Stockholders’ equity:    
Preferred stock – par value $.10 per share; authorized 1,000,000 shares; none issued 0 0
Common stock – par value $.10 per share; authorized 40,000,000 shares; issued – 21,092,617 shares at March 31, 2026 and 21,092,617 shares at December 31, 2025; outstanding – 16,656,503 shares at March 31, 2026 and 16,656,503 shares at December 31, 2025 2,109 2,109
Capital in excess of par value 192,858 192,859
Accumulated deficit (40,791) (40,340)
Accumulated other comprehensive loss (3,058) (3,141)
Treasury stock - at cost; 4,436,114 shares at March 31, 2026 and 4,436,114 shares at December 31, 2025 (21,492) (21,492)
Total Ultralife Corporation equity 129,626 129,995
Non-controlling interest 119 139
Total stockholders’ equity 129,745 130,134
Total liabilities and stockholders’ equity $ 220,632 $ 216,912